PTHL: Pheton Holdings Net Assets per Single Share

Symbol and logo of brand Pheton Holdings (PTHL)

Pheton Holdings Ltd (PTHL) develops brachytherapy software through partnerships with Chinese oncology centers. The book value per share reflects the dynamics of net assets, where the 0.28 indicator determines the metric's value. The company's growth is based on the digitalization of healthcare in the PRC, although the narrow niche of IT solutions for oncology limits the overall addressable market.

PTHL Pheton Share Book Value (09/06/2024 - 01/16/2026)
Manufactured products of Pheton

Book value per share reflects the portion of net assets attributable to a single security, allowing for an assessment of the business's actual tangible base net of liabilities. By analyzing the book value per share for Pheton Holdings Ltd. (PTHL) on GURU.Markets, an investor can see the capitalization of the company's radiotherapy equipment, which confirms the financial stability of Pheton Holdings Ltd. during its expansion within the Chinese medical technology market.

Competitor analysis

Haleon Group - Book Value per Share|Accounting Value of a Share KVUE (Kenvue Health)|Verona Pharma plc (VRNA) - Net Assets per Single Share|MENS (jyongbio.com) - Net Assets per Single Share|Net Assets per Single Share Ligand|Amneal Pharmaceuticals, Inc. - Share Book Value|Book Value per Share PRGO|ALVO (Alvotech Biopharmaceuticals) - Accounting Value of a Share|Book Value per Share LQDA (Liquidia Corporation)|Book Value per Share glpg.com GLPG|ANIP - Net Assets per Single Share|Accounting Value of a Share MNKD (MannKind Corp)|Amphastar (AMPH) - Net Assets per Single Share|Accounting Value per Share Pacira Corp|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share theravance.com|Accounting Value per Share AQST (Aquestive Therapeutics, Inc.)|SCPH (scpharmaceuticals.com) - Accounting Value of a Share|Net Assets per Single Share Tectonic Therapeutic TECX|Tonix Pharmaceuticals Holding (TNXP) - Net Asset Value per Share|SXTC: Accounting Value per Share|Eupraxia Pharmaceuticals - Book Price of a Share|BHST: Book Value per Share|Invizyne Technologies - Accounting Value of a Share|ORMP (Oramed) - Book Value per Share|Net Asset Value per Share Entera Bio Corp ENTX|Net Assets per Single Share MindWalk Holdings (HYFT)|ABVC (abvcpharma.com) - Accounting Value of a Share|Net Assets per Single Share Cumberland Pharmaceuticals Inc. CPIX|QNTM (Quantum BioPharma Ltd.) - Share Book Value|FibroGen Corp - Book Value per Share|Accounting Value of a Share TELO (Telomir Pharmaceuticals Corp)|RANI: Book Value per Share|Net Asset Value per Share Synergy CHC (SNYR)|Accounting Value per Share RLYB|LEXX (Lexaria) - Book Price of a Share|Net Assets per Single Share Pulmatrix Corp (PULM)|APM - Net Asset Value per Share|Net Assets per Single Share Lyra Therapeutics, Inc. LYRA|IBO: Equity per Share|TNFA: Accounting Value per Share|Accounting Value of a Share YCBD (cbdMD, Inc.)|PRFX: Book Value per Share|Altamira Therapeutics Ltd. - Accounting Value of a Share|Net Assets per Single Share Lipella Pharmaceuticals|Net Asset Value per Share optinose.com OPTN|Net Assets per Single Share Pieris Pharmaceuticals, Inc. (PIRS)|Net Assets per Single Share PROC (Procaps Group)|Book Value per Share PTPI (Petros)|QLI: Equity per Share|Acelyrin, Inc. - Book Value per Share|Net Assets per Share tffpharma.com TFFP